In vitro, CASC2 overexpression dramatically repressed HCC cell proliferation and inhibited cell apoptosis; in vivo, CASC2 overexpression inhibited subcutaneous xenotransplant tumor growth, confirming the tumor-suppressive role in HCC. The gene discussed is CASC2; the disease is hepatocellular carcinoma.